However, the addition of the Glucagon receptor agonist is the true game-changer. Glucagon signaling increases energy expenditureessentially telling the body to use its stored energy more efficiently
While GLP-1 agonists can play a valuable role in health goals, 42% of patients are concerned about potential unwanted outcomes of semaglutides. DaVinci Laboratories offers a range of nutritional support options for common unwanted effects of semaglutides.* Together with diet and lifestyle changes, they can provide a comprehensive program for achieving metabolic health and body weight goals.* Fill out the form and download a PDF version of the guide you can reference later
What this means for providers For clinicians, the practical takeaway is about judgment and communication , not protocols
Again, that has a lot to do with the additional hormonal pathway
When Pinto has a patient who asks about weaning off their GLP-1 or spacing out dosing, he is very receptive to the conversation
The program is not appropriate for every applicant